Abbott Laboratories

ABT: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
^fvLOCK|>v#F#LOCK|C!>J%k

Abbott Earnings: Weakness in US Markets Softened by Strength in Foreign Markets

Abbott's first-quarter results featured 4% organic revenue growth and adjusted net earnings growth of 5% year over year. Medical devices were up 9%, more than offsetting the nutrition revenue decline of 8%.

Sponsor Center